← Back to News

Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products

negativeLegalMulti dayYahoo Finance ·23 Jun 2026Original article ↗
Oraklio AI Analysis

A product recall involving potential contamination is typically viewed negatively for the issuing company and can drive short-term trading volatility, even if limited to specific lots and no adverse events have been reported. The article also mentions a separate sell-side price-target cut/Neutral stance, reinforcing caution.

Article

Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products Venkatesh Tue, June 23, 2026 at 10:35 AM GMT+2 2 min read BDX Becton, Dickinson and Company (NYSE: BDX ) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now . Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products On June 6, 2026, Becton, Dickinson and Company (NYSE:BDX) issued a nationwide voluntary recall for specific lots of its ChloraPrep™ Clear 1 mL and FREPP™ Clear 1. 5 mL skin preparation applicators due to potential fungal contamination (Aspergillus penicillioides).

4032183 and 4073005 were the two affected lots, which were distributed to hospitals and suppliers between March and June 2024. Contamination by the fungus poses severe risks, including systemic infection, sepsis, and surgical complications. No adverse events have been reported yet.

However, the company advises customers to stop using the product immediately and destroy the recalled products. Becton, Dickinson and Company (NYSE:BDX) intends to provide replacements for these products. Meanwhile, on June 12, 2026, Bank of America lowered its price target on Becton, Dickinson and Company (NYSE:BDX) from $177 to $170, maintaining a Neutral rating.

The analyst cited a lower utilization environment and an increase in inflation headwinds for 2027, as the firm adopted a more conservative outlook on medtech companies. BofA also reduced 2027 estimates across its large-cap medtech coverage to account for utilization and margin compression risks. Earlier this month, on June 3, 2026, Jim Cramer expressed confidence in the stock.

I like Becton, Dickinson. It is selling frankly at the lowest level to the market that I have ever seen. I think you buy some and then you wait to see if they even oversell it more.

That stock is very inexpensive. Founded in 1897, Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company headquartered in New Jersey. The company manufactures and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.

While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the   best short-term AI stock . READ NEXT:  10 Safest Dividend Stocks to Buy Right Now  and  Chase Coleman’s Tiger Global Portfolio: 10 Best Stocks to Buy Disclosure: None.

Follow Insider Monkey on Google News .

Oraklio AI Trading Intelligence

News is just the start.

Oraklio turns news, price data, and market signals into structured BUY / SELL / NO_TRADE calls - updated continuously throughout the trading day.

Get started free

Already have an account? Sign in →